ArticleDiabetes, obesity & metabolism2026

Glucagon-Like Peptide-1 Receptor Agonists and Incident Major Adverse Liver Outcomes in People With Type 2 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease.

Gregor A Maier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.